Masoprocol

马索罗酚

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMasoprocol
Drug Alias Name马索丙考Nordihydroguaiaretic acidActinexSP-134101meso-NDGA +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsKeratosis, ActinicProstatic Neoplasms
Global Approved IndicationsKeratosis, Actinic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1992/09/04
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoThe University Of Arizona
Active IndicationsN/A
Inactive IndicationsKeratosis, ActinicProstatic Neoplasms

Other Information

ATC CodeL01XX10
Related LinksWikipediaDrugBankKEGG